Cardiovascular diseases in sarcoidosis
Dobin, V.L.; Kalinichev, G.A.
Problemy Tuberkuleza 2: 71-74
1991
ISSN/ISBN: 0032-9533 PMID: 2034651 Document Number: 374902
Document emailed within 1 workday
Related Documents
Weser, C.; Klessen, D. 1978: Strategy for the control of cardiovascular diseases in a metropolis (demonstrated by the Berlin concept of a unified system of care for patients with cardiovascular diseases) Zeitschrift für Arztliche Fortbildung 72(20): 967-9711999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Jobin, F. 1976: Blood platelets and cardiovascular diseases. III. Diseases with increased platelet consumption and vascular diseases L'Union Medicale du Canada 105(5): 756-766
McManus, B.M.; Wilson, J.E.; Struve, L.C. 1993: Manpower deficiencies in cardiovascular pathology. Implications for medical care of cardiovascular diseases Archives of Pathology and Laboratory Medicine 117(6): 584-588
Makar, O.; Siabrenko, G. 2018: Influence of Physical Activity on Cardiovascular System and Prevention of Cardiovascular Diseases (Review) Georgian Medical News 2018(285): 69-74
Chopeĭ, I.V.; Rosul, M.M.; Hechko, M.M.; Chubirko, K.I.; Korabel'shchykova, M.O.; Ivan'o, N.V. 2014: Cardiovascular continuum: the role of the family doctor in prevention of cardiovascular diseases Wiadomosci Lekarskie 67(2 Pt 2): 243-247
Ezzine Sebai, N.; Sioud Dhrif, A.; Kharfi, M.; Khaled, A.; Fazaa, B.éc.; Zeglaoui, F.; Komoun, M.R. 2008: Cutaneous sarcoidosis revealed by coexistence of subcutaneous sarcoidosis and scar sarcoidosis La Tunisie Medicale 86(10): 936
Gao, J.; Liang, X.; Shi, J.; Huang, Z.; Wei, X.; Li, H.; Lin, L.; Xing, A.; Du, X.; Wu, S. 2014: Impact of ideal cardiovascular health behaviors and factors on resting heart rate in individuals without cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 42(9): 778-783
Schoppet, M.; Pankuweit, S.; Moll, R.; Baandrup, U.; Maisch, B. 2002: Images in cardiovascular medicine. Phenotype of infiltrating T lymphocytes in cardiac sarcoidosis Circulation 105(12): E67-E68
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
Tuomilehto, J.; Kuulasmaa, K.; Torppa, J. 1987: WHO MONICA Project: geographic variation in mortality from cardiovascular diseases. Baseline data on selected population characteristics and cardiovascular mortality World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 40(2): 171-184
Sanz, M.; D'Aiuto, F.; Deanfield, J.; Fernandez-Aviles, F. 2010: European workshop in periodontal health and cardiovascular disease--scientific evidence on the association between periodontal and cardiovascular diseases: a review of the literature European Heart Journal Suppls 12(Suppl B): B3-B12
Monarca, S.; Zerbini, I.; Simonati, C.; Gelatti, U. 2003: Drinking water hardness and chronic degenerative diseases. II. Cardiovascular diseases Annali di Igiene: Medicina Preventiva e di Comunita 15(1): 41-56
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Douglas, S.D.; Schmidt, M.E. 1977: Mononuclear phagocytes in sarcoidosis and granulomatous diseases Mount Sinai Journal of Medicine new York 44(6): 761-766
Anastasatu, C.; Albu, A.; Burnea, D.; Didilescu, C.; Gîrlonţa, V.; Mihălţan, P.; Popescu, N.; Savu, A.; Udrea, S.; Păunescu, E. 1989: The advantages of Reprimum therapy in pulmonary sarcoidosis and other granulomatous diseases Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 38(3): 259-264
Schweisfurth, H.; Heinrich, J.; Brugger, E.; Wernze, H.; Wichmann, J.; Ertl, G. 1983: Angiotensin i converting enzyme and carboxypeptidase B-like enzymes in sarcoidosis and other lung diseases Praxis und Klinik der Pneumologie 37(Suppl 1): 562-564
Weiss, B.M.; Hess, O. 1997: Perioperative cardiovascular evaluation for noncardiac surgery: congenital heart diseases and heart diseases in pregnancy deserve better guidelines Circulation 95(2): 530-531
Tsumura, K. 2007: Working despite having diseases: Cardiovascular diseases Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 139: 29-38